Meaning of Life in HIV-infected Youths
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT01644383|
Recruitment Status : Completed
First Posted : July 19, 2012
Last Update Posted : August 18, 2016
|Condition or disease||Intervention/treatment||Phase|
|Meaning of Life||Behavioral: logotherapy||Not Applicable|
|Study Type :||Interventional (Clinical Trial)|
|Actual Enrollment :||48 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Official Title:||Meaning in Life of Youth Infected With HIV|
|Study Start Date :||February 2011|
|Actual Primary Completion Date :||June 2015|
|Actual Study Completion Date :||June 2015|
Experimental: Treatment arm (logotherapy)
Participants in Arm I will attend the logotherapy group sessions by the trained psychologist for 4 visits (see Table II, III). The number of participants in group sessions will be 20 participants per group.
Logotherapy is therapy during which the interaction between the therapist and the client centres on the topic of meaning. The problems that the clients experience are presented to the client as inseparable parts of his everyday life. The client is then challenged to discover his/her meaning and to take responsibility in facing up to his/her problem. This approach is aimed at helping the client to deal and understand what his /her existences entail.
No Intervention: Control arm (general health education)
Participants in Arm II will attend the routine health education by the nurse. The number of participants in group session will be 20 participants per group.
- PIL score [ Time Frame: week 48 ]Change of PIL score at baseline and follow up visit between the two arms
- QOL [ Time Frame: 48 weeks ]
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01644383
|HIV-NAT, the Thai Red Cross AIDS Research Centre|
|Bangkok, Thailand, 10330|
|Principal Investigator:||Arunya Tuicomepee, PhD||Chulalongkorn University|